Navigation Links
Pediatricians alerted to the developmental nature of underage drinking in special journal supplement
Date:4/6/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):University of Washington professor garners Avanti Young Investigator Award 2Vermicompost from pig manure grows healthy hibiscus 2'Fighting' IED attacks with SCARE technology 2'Fighting' IED attacks with SCARE technology 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 1The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 2The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 3The MedZilla Report for October 2009 Health Care Employment Grows Again in October Even As Clinics Specialty Centers Close 14966 4Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 1Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 2Senate Votes to Proceed 60 Plus Announces New 9 State TV Campaign Targeted at Senators to Protect Medicare 62049 3deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 1deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 2deCODE genetics Inc Announces Approval of First Day Motions by Bankruptcy Court 14965 3
Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4